Clevexel Pharma
France - ParisPharmaceutical
Focus: Clevexel Pharma is a French pharmaceutical company focused on CNS treatments, specifically neurology indications. The company's scale, stage, and financial position are not publicly disclosed.
Profile data last refreshed 20h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Clevexel Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Clevexel Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CVXL-0107
Idiopathic Parkinson DiseaseClinical Trials (1)
NCT02641054Efficacy Phase IIa Study of CVXL-0107 in Advanced Parkinson's Disease
Phase 2Help build intelligence for Clevexel Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.